Back
Sarepta Therapeutics Vs. Griffon Industry Stock Comparison
Sell
31
SRPT
Sarepta Therapeutics
Last Price:
109.05
Seasonality Move:
19.2%
Buy
70
GFF
Griffon
Last Price:
77.38
Seasonality Move:
14.29%
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $112.48. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Griffon (GFF)
is a Buy
Is Griffon a Buy, Sell or Hold?
- The current Griffon [GFF] share price is $80.52. The Score for GFF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- GFF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $112.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
GFF Stock Price Chart
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.6 | Sell |
Relative Strength Index (14 RSI): | 30.53 | Sell |
Chaikin Money Flow: | -576241 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
GFF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.42 | Buy |
Relative Strength Index (14 RSI): | 78.19 | Buy |
Chaikin Money Flow: | 1692432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 120.33 | Sell |
20-day SMA: | 125.09 | Sell |
50-day SMA: | 124.91 | Sell |
200-day SMA: | 130.53 | Sell |
8-day EMA: | 119.07 | Sell |
20-day EMA: | 122.65 | Sell |
50-day EMA: | 126.04 | Sell |
200-day EMA: | 127.3 | Sell |
GFF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 68.94 | Buy |
20-day SMA: | 66.4 | Buy |
50-day SMA: | 66.92 | Buy |
200-day SMA: | 67.26 | Buy |
8-day EMA: | 70.29 | Buy |
20-day EMA: | 67.85 | Buy |
50-day EMA: | 67.02 | Buy |
200-day EMA: | 63.95 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.
Griffon Earnings Growth & GFF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.70 per share.
Sarepta Therapeutics Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Griffon Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |